Found: 83
Select item for more details and to access through your institution.
Evidence for shoulder girdle dystonia in selected patients with cervical disc prolapse.
- Published in:
- Movement Disorders, 2002, v. 17, n. 4, p. 710, doi. 10.1002/mds.10132
- By:
- Publication type:
- Article
Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study.
- Published in:
- Multiple Sclerosis Journal, 2019, v. 25, n. 6, p. 819, doi. 10.1177/1352458518771875
- By:
- Publication type:
- Article
Safety and efficacy of cladribine tablets in patients with relapsing–remitting multiple sclerosis: Results from the randomized extension trial of the CLARITY study.
- Published in:
- Multiple Sclerosis Journal, 2018, v. 24, n. 12, p. 1594, doi. 10.1177/1352458517727603
- By:
- Publication type:
- Article
Reduction in Healthcare and Societal Resource Utilization Associated with Cladribine Tablets in Patients with Relapsing-Remitting Multiple Sclerosis.
- Published in:
- Clinical Drug Investigation, 2012, v. 32, n. 1, p. 15, doi. 10.2165/11593310-000000000-00000
- By:
- Publication type:
- Article
Microglial/macrophage expression of interleukin 10 in human glioblastomas.
- Published in:
- International Journal of Cancer, 1999, v. 82, n. 1, p. 12, doi. 10.1002/(SICI)1097-0215(19990702)82:1<12::AID-IJC3>3.0.CO;2-O
- By:
- Publication type:
- Article
Speed but Not Smoothness of Gait Reacts to Rehabilitation in Multiple Sclerosis.
- Published in:
- Multiple Sclerosis International, 2021, p. 1, doi. 10.1155/2021/5589562
- By:
- Publication type:
- Article
Future of Management of Multiple Sclerosis in the Middle East: A Consensus View from Specialists in Ten Countries.
- Published in:
- Multiple Sclerosis International, 2013, p. 1, doi. 10.1155/2013/952321
- By:
- Publication type:
- Article
Escalating Immunotherapy with Mitoxantrone in Patients with Very Active Relapsing-Remitting or Progressive Multiple Sclerosis.
- Published in:
- European Neurology, 2000, v. 43, n. 3, p. 186, doi. 10.1159/000008163
- By:
- Publication type:
- Article
Acute Inflammatory CNS Disease after MDMA ('Ecstasy').
- Published in:
- European Neurology, 1996, v. 36, n. 5, p. 328, doi. 10.1159/000117286
- By:
- Publication type:
- Article
(DXT26) Long-Term Disease Stability Assessed by the Expanded Disability Status Scale in Patients Treated with Cladribine Tablets in the CLARITY and CLARITY Extension Studies.
- Published in:
- International Journal of MS Care, 2020, v. 22, n. S2, p. 25
- By:
- Publication type:
- Article
Atorvastatin partially prevents an inflammatory barrier breakdown of cultured human brain endothelial cells at a pharmacologically relevant concentration.
- Published in:
- Journal of Neurochemistry, 2007, v. 102, n. 4, p. 1001, doi. 10.1111/j.1471-4159.2007.04563.x
- By:
- Publication type:
- Article
Going beyond PA: Assessing sensorimotor capacity with wearables in multiple sclerosis—a cross-sectional study.
- Published in:
- Journal of NeuroEngineering & Rehabilitation (JNER), 2023, v. 20, n. 1, p. 1, doi. 10.1186/s12984-023-01247-z
- By:
- Publication type:
- Article
Common Cellular and Diverse Genetic Basis of Thymoma-associated Myasthenia Gravis.
- Published in:
- Annals of the New York Academy of Sciences, 2008, v. 1132, p. 143, doi. 10.1196/annals.1405.018
- By:
- Publication type:
- Article
Assessment of microRNA-related SNP effects in the 3′ untranslated region of the IL22RA2 risk locus in multiple sclerosis.
- Published in:
- Neurogenetics, 2014, v. 15, n. 2, p. 129, doi. 10.1007/s10048-014-0396-y
- By:
- Publication type:
- Article
Efficacy and safety of a three-times-weekly dosing regimen of glatiramer acetate in relapsing–remitting multiple sclerosis patients: 3-year results of the Glatiramer Acetate Low-Frequency Administration open-label extension study.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 6, p. 818, doi. 10.1177/1352458516664033
- By:
- Publication type:
- Article
Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome.
- Published in:
- Multiple Sclerosis Journal, 2013, v. 19, n. 8, p. 1074, doi. 10.1177/1352458512469695
- By:
- Publication type:
- Article
Characteristics of multiple sclerosis in aboriginals living in British Columbia, Canada.
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 9, p. 1239, doi. 10.1177/1352458512436595
- By:
- Publication type:
- Article
Temporal trends of disability progression in multiple sclerosis: findings from British Columbia, Canada (1975–2009).
- Published in:
- Multiple Sclerosis Journal, 2012, v. 18, n. 4, p. 442, doi. 10.1177/1352458511422097
- By:
- Publication type:
- Article
Three times weekly glatiramer acetate in relapsing-remitting multiple sclerosis.
- Published in:
- Annals of Neurology, 2013, v. 73, n. 6, p. 705, doi. 10.1002/ana.23938
- By:
- Publication type:
- Article
Interferon-β Is a Potent Inducer of Interferon Regulatory Factor-1/2-Dependent IP-10/CXCL10 Expression in Primary Human Endothelial Cells.
- Published in:
- Journal of Vascular Research, 2007, v. 44, n. 1, p. 51, doi. 10.1159/000097977
- By:
- Publication type:
- Article
A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 +49) alters T-cell activation.
- Published in:
- Immunogenetics, 2002, v. 54, n. 1, p. 1, doi. 10.1007/s00251-002-0429-9
- By:
- Publication type:
- Article
Long-term efficacy and safety of three times weekly dosing regimen of glatiramer acetate in relapsing multiple sclerosis patients: Seven-year results of the Glatiramer Acetate Low-frequency Administration (GALA) open-label extension study.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2021, p. 1, doi. 10.1177/20552173211061550
- By:
- Publication type:
- Article
Long-term efficacy and safety of three times weekly dosing regimen of glatiramer acetate in relapsing multiple sclerosis patients: Seven-year results of the Glatiramer Acetate Low-frequency Administration (GALA) open-label extension study.
- Published in:
- Multiple Sclerosis Journal - Experimental, Translational & Clinical, 2021, v. 7, n. 4, p. 1, doi. 10.1177/20552173211061550
- By:
- Publication type:
- Article
Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis.
- Published in:
- 2016
- By:
- Publication type:
- Case Study
Early Intervention in Multiple Sclerosis: Better Outcomes for Patients and Society?
- Published in:
- Drugs, 2003, v. 63, n. 15, p. 1525, doi. 10.2165/00003495-200363150-00001
- By:
- Publication type:
- Article
EPIBLASTER-fast exhaustive two-locus epistasis detection strategy using graphical processing units.
- Published in:
- European Journal of Human Genetics, 2011, v. 19, n. 4, p. 465, doi. 10.1038/ejhg.2010.196
- By:
- Publication type:
- Article
Summary of Research: Collaboration Between Healthcare Professionals and People with Multiple Sclerosis to Develop Communication Tools to Improve the Standard of Multiple Sclerosis Care.
- Published in:
- Advances in Therapy, 2023, v. 40, n. 12, p. 5131, doi. 10.1007/s12325-023-02638-3
- By:
- Publication type:
- Article
Adherence to Subcutaneous Interferon Beta-1a in Multiple Sclerosis Patients Receiving Periodic Feedback on Drug Use by Discussion of Readouts of Their Rebismart<sup>®</sup> Injector: Results of the Prospective Cohort Study REBIFLECT.
- Published in:
- Advances in Therapy, 2022, v. 39, n. 6, p. 2749, doi. 10.1007/s12325-022-02100-w
- By:
- Publication type:
- Article
Long-Term Disease Stability Assessed by the Expanded Disability Status Scale in Patients Treated with Cladribine Tablets 3.5 mg/kg for Relapsing Multiple Sclerosis: An Exploratory Post Hoc Analysis of the CLARITY and CLARITY Extension Studies.
- Published in:
- Advances in Therapy, 2021, v. 38, n. 9, p. 4975, doi. 10.1007/s12325-021-01865-w
- By:
- Publication type:
- Article
Joint Healthcare Professional and Patient Development of Communication Tools to Improve the Standard of MS Care.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Adherence to Subcutaneous IFN β-1a in Multiple Sclerosis: Final Analysis of the Non-Interventional Study READOUTsmart Using the Dosing Log and Readout Function of RebiSmart<sup>®</sup>.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Neue immungenetische Aspekte der multiplen Sklerose.
- Published in:
- Neuroforum, 2001, v. 7, n. 4, p. 121, doi. 10.1515/nf-2001-0403
- By:
- Publication type:
- Article
Alemtuzumab as rescue therapy in a cohort of 50 relapsing-remitting MS patients with breakthrough disease on fingolimod: a multi-center observational study.
- Published in:
- Journal of Neurology, 2018, v. 265, n. 7, p. 1521, doi. 10.1007/s00415-018-8871-2
- By:
- Publication type:
- Article
Multiple sclerosis in the Arabian Gulf countries: a consensus statement.
- Published in:
- Journal of Neurology, 2013, v. 260, n. 12, p. 2959, doi. 10.1007/s00415-013-6876-4
- By:
- Publication type:
- Article
MRI outcomes with cladribine tablets for multiple sclerosis in the CLARITY study.
- Published in:
- Journal of Neurology, 2013, v. 260, n. 4, p. 1136, doi. 10.1007/s00415-012-6775-0
- By:
- Publication type:
- Article
Future MS care: a consensus statement of the MS in the 21st Century Steering Group.
- Published in:
- Journal of Neurology, 2013, v. 260, n. 2, p. 462, doi. 10.1007/s00415-012-6656-6
- By:
- Publication type:
- Article
Changes in thumb tapping rates and central motor conduction times are associated in persons with multiple sclerosis.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Can Growth Hormone Lead to a Faster Recovery from Guillain-Barré Syndrome? Case Report of the First Therapeutic Use in One Patient.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Genetic polymorphism of the tumor necrosis factor (TNF)-α promoter region in families with localized early-onset periodontitis.
- Published in:
- Journal of Periodontal Research, 2001, v. 36, n. 3, p. 183, doi. 10.1034/j.1600-0765.2001.360307.x
- By:
- Publication type:
- Article
Evaluation of Soluble Junctional Adhesion Molecule-A as a Biomarker of Human Brain Endothelial Barrier Breakdown.
- Published in:
- PLoS ONE, 2010, v. 5, n. 10, p. 1, doi. 10.1371/journal.pone.0013568
- By:
- Publication type:
- Article
mtDNA nt13708A Variant Increases the Risk of Multiple Sclerosis.
- Published in:
- PLoS ONE, 2008, v. 3, n. 2, p. 1, doi. 10.1371/journal.pone.0001530
- By:
- Publication type:
- Article
SPARC expression by cerebral microvascular endothelial cells in vitro and its influence on blood-brain barrier properties.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2021, p. 1, doi. 10.1177/17562864211058298
- By:
- Publication type:
- Article
Expert opinion on COVID-19 vaccination and the use of cladribine tablets in clinical practice.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2021, p. 1, doi. 10.1177/17562864211058298
- By:
- Publication type:
- Article
Expert opinion on the use of cladribine tablets in clinical practice.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2020, v. 13, p. 1, doi. 10.1177/1756286420935019
- By:
- Publication type:
- Article
Treatment de-escalation after mitoxantrone therapy: results of a phase IV, multicentre, open-label, randomized study of subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2012, v. 5, n. 1, p. 3, doi. 10.1177/1756285611428503
- By:
- Publication type:
- Article
Review: Escalating immunotherapy of multiple sclerosis.
- Published in:
- Therapeutic Advances in Neurological Disorders, 2008, v. 1, n. 3, p. 181, doi. 10.1177/1756285608098359
- By:
- Publication type:
- Article
Excitability decreasing central motor plasticity is retained in multiple sclerosis patients.
- Published in:
- BMC Neurology, 2012, v. 12, n. 1, p. 92, doi. 10.1186/1471-2377-12-92
- By:
- Publication type:
- Article
State and trait of finger tapping performance in multiple sclerosis.
- Published in:
- Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-96485-3
- By:
- Publication type:
- Article
Haematological effects of interferon-beta-1a (Rebif) therapy in multiple sclerosis.
- Published in:
- 2004
- By:
- Publication type:
- journal article